Clinical Trial Update: A Study to Assess the Safety and Pharmacokinetics of AD-104-A [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and pharmacokinetics of AD-104-A in hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• AD-104-A

Snippet

Sponsor: Addpharma Inc. | Conditions: Hyperlipidemias | Phase 1 | Status: COMPLETED